Biotransformation of cibenzoline to 2-(2,2-diphenylcyclopropyl)-1H-imidazole

Autor: J. J. Carbone, J. L. Kovacs, J. W. Tilley, Thomas H. Williams, A J Szuna, A C Loh, D. Pace, Gino J. Sasso, F J Leinweber, P. Dahlen, M. Cazes, L. R. Klevans

Publikováno v: Xenobiotica; the fate of foreign compounds in biological systems. 13(5)

A microsomal metabolite of cibenzoline, 4,5-dihydro-2-(2,2-diphenylcyclopropyl)-1H-imidazole butanedioate, was identified by n.m.r. as the 4,5-dehydro analogue, 2-(2,2-diphenylcyclopropyl)-1H-imidazole. Three dogs dosed orally with 13.8 mg/kg 14C-cib

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e22f65dbedb00d0680a1220e67a0ddf3
https://pubmed.ncbi.nlm.nih.gov/6636825

Sclerostin and bone turnover markers response to cycling and running at the same moderate-to-vigorous exercise intensity in healthy men.

Autor: Dror N; Pediatric Exercise and Genomics Research Center, Department of Pediatrics, School of Medicine, University of California Irvine, 101 Academy, Suite 150, Irvine, CA, 92617, USA., Carbone J; Pediatric Exercise and Genomics Research Center, Department of Pediatrics, School of Medicine, University of California Irvine, 101 Academy, Suite 150, Irvine, CA, 92617, USA., Haddad F; Pediatric Exercise and Genomics Research Center, Department of Pediatrics, School of Medicine, University of California Irvine, 101 Academy, Suite 150, Irvine, CA, 92617, USA., Falk B; Department of Kinesiology, Faculty of Applied Health Sciences, Brock University, St. Catharines, ON, Canada.; Centre for Bone and Muscle Health, Brock University, St. Catharines, ON, Canada., Klentrou P; Department of Kinesiology, Faculty of Applied Health Sciences, Brock University, St. Catharines, ON, Canada.; Centre for Bone and Muscle Health, Brock University, St. Catharines, ON, Canada., Radom-Aizik S; Pediatric Exercise and Genomics Research Center, Department of Pediatrics, School of Medicine, University of California Irvine, 101 Academy, Suite 150, Irvine, CA, 92617, USA. saizik@uci.edu.

Publikováno v: Journal of endocrinological investigation [J Endocrinol Invest] 2022 Feb; Vol. 45 (2), pp. 391-397. Date of Electronic Publication: 2021 Aug 14.

Multicenter study for the evaluation of the antibody response against salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of Anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency.

Autor: Sánchez-Ramón S; Clinical Immunology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Electronic address: ssramon@salud.madrid.org., de Gracia J; Pneumology, Hospital Universitari Vall d'Hebrón, Barcelona, Spain., García-Alonso AM; Immunology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain., Rodríguez Molina JJ; Clinical Immunology, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Melero J; Immunology, Hospital Infanta Cristina, Badajoz, Spain., de Andrés A; Immunology, Hospital Universitario Ramón y Cajal, Madrid, Spain., García Ruiz de Morales JM; Immunology, Hospital de León, Leon, Spain., Ferreira A; Immunology, Hospital Universitario La Paz, Madrid, Spain., Ocejo-Vinyals JG; Immunology, Hospital Marqués de Valdecilla, Santander, Spain., Cid JJ; Immunology, Hospital Juan Canalejo, La Coruña, Spain., García Martínez JM; Pediatrics, Hospital de Cruces, Bilbao, Spain., Lasheras T; Pneumology, Hospital Universitari Vall d'Hebrón, Barcelona, Spain., Vargas ML; Immunology, Hospital Infanta Cristina, Badajoz, Spain., Gil-Herrera J; Clinical Immunology, Hospital General Universitario Gregorio Marañón, Madrid, Spain., García Rodríguez MC; Immunology, Hospital Universitario La Paz, Madrid, Spain., Castañer JL; Immunology, Hospital Universitario La Paz, Madrid, Spain., González Granado LI; Pediatric Infectious Diseases and Immunodeficiencies Unit, Pediatrics, Hospital 12 de Octubre, Madrid, Spain., Allende LM; Immunology, Hospital 12 de octubre, Madrid, Spain., Soler-Palacin P; Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Herráiz L; Clinical Immunology, Hospital General Universitario Gregorio Marañón, Madrid, Spain., López Hoyos M; Immunology, Hospital Marqués de Valdecilla, Santander, Spain., Bellón JM; Statistics, Hospital General Universitario Gregorio Marañón, Spain., Silva G; Immunology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Gurbindo DM; Immunopediatrics, Hospital Maternoinfantil de O'Donnell, Madrid, Spain., Carbone J; Clinical Immunology, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Rodríguez-Sáinz C; Clinical Immunology, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Matamoros N; Immunology, Hospital Son Espases, Palma de Mallorca, Spain., Parker AR; The Binding Site Group Ltd, Birmingham, UK., Fernández-Cruz E; Clinical Immunology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Publikováno v: Clinical immunology (Orlando, Fla.) [Clin Immunol] 2016 Aug; Vol. 169, pp. 80-84. Date of Electronic Publication: 2016 May 25.

Challenges associated with immunological scores for the prediction of the risk of infection after transplant.

Autor: Sarmiento E; Clinical Immunology Department, University Hospital Gregorio Marañon, Madrid, Spain., Carbone J

Publikováno v: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2015 Feb; Vol. 17 (1), pp. 156-7. Date of Electronic Publication: 2015 Jan 09.

Evaluation of an immunological score to assess the risk of severe infection in heart recipients.

Autor: Sarmiento E; Clinical Immunology Department, University Hospital Gregorio Marañon, Madrid, Spain., Navarro J, Fernandez-Yañez J, Palomo J, Muñoz P, Carbone J

Publikováno v: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2014 Oct; Vol. 16 (5), pp. 802-12. Date of Electronic Publication: 2014 Sep 01.